ORBIMED ADVISORS LLC is an institutional investment manager that files quarterly 13F reports with the SEC. As of Q2 2026, the fund manages $5.4B in reported equity holdings across 123 positions. The largest holdings are EWTX (11.7%), ELVN (6.4%), LLY (5.7%), MBX (3.5%), SVA (3.4%). The portfolio is concentrated in Other (84.1%), Healthcare (15.9%). Data sourced from SEC EDGAR 13F filings (CIK 1055951).